Roland Martin
Science · 2000–2019
A researcher in the Science corpus: 6 papers; trusts 0 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Whom Roland Martin trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Roland Martin overall
Papers from Roland Martin's perspective
Ordered by how strongly the researchers Roland Martin trusts endorse each paper. Same corpus, a different order for every researcher.
- Essential autocrine regulation by IL-21 in the generation of inflammatory T cells (Nature)
- Glutamate excitotoxicity in a model of multiple sclerosis (Nature Medicine)
- Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. (Brain : a journal of neurology)
- B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. (New England Journal of Medicine)
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
- Genome-partitioning of genetic variation for complex traits using common SNPs (Nature Genetics)
- Biological interpretation of genome-wide association studies using predicted gene functions (Nature Communications)
- Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci (Nature Genetics)
- Common SNPs explain a large proportion of heritability for human height (Nature Genetics)
- Systematic Localization of Common Disease-Associated Variation in Regulatory DNA (Science)
Their papers
- Multiple Sclerosis Genomic Map implicates peripheral immune cells & microglia in susceptibility (2019) — 1,186 citations
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis (2011) — 2,780 citations
- Multiple sclerosis: a complicated picture of autoimmunity (2007) — 1,064 citations
- Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. (2006) — 625 citations
- Immunology of multiple sclerosis. (2005) — 960 citations
- Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand (2000) — 842 citations